A Phase 3 Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

Conditions:   Oral Mucositis;   Head and Neck Cancer
Interventions:   Drug: GC4419;   Drug: Placebo
Sponsor:   Galera Therapeutics, Inc.
Not yet recruiting

https://ift.tt/2OVyulB